Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
46.52
+2.28 (5.15%)
At close: Mar 13, 2026, 4:00 PM EDT
47.50
+0.98 (2.11%)
After-hours: Mar 13, 2026, 7:59 PM EDT
Terns Pharmaceuticals Employees
Terns Pharmaceuticals had 59 employees as of December 31, 2024. The number of employees decreased by 7 or -10.61% compared to the previous year.
Employees
59
Change (1Y)
-7
Growth (1Y)
-10.61%
Revenue / Employee
n/a
Profits / Employee
-$1,600,593
Market Cap
4.19B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 59 | -7 | -10.61% |
| Dec 31, 2023 | 66 | 20 | 43.48% |
| Dec 31, 2022 | 46 | 5 | 12.20% |
| Dec 31, 2021 | 41 | 11 | 36.67% |
| Dec 31, 2020 | 30 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,769 |
| PTC Therapeutics | 991 |
| Amicus Therapeutics | 511 |
| CRISPR Therapeutics AG | 393 |
| Mirum Pharmaceuticals | 372 |
| Immunovant | 362 |
| Scholar Rock Holding | 289 |
| Apogee Therapeutics | 261 |
TERN News
- 17 days ago - Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences - GlobeNewsWire
- 5 weeks ago - Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 7 weeks ago - These 20 stocks are strong choices for momentum investors - Market Watch
- 2 months ago - Terns Pharmaceuticals, Inc. (TERN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 3 months ago - Terns Announces Pricing of Upsized $650 Million Public Offering - GlobeNewsWire
- 3 months ago - Cancer Study Buoys These Small Biotechs - Barrons